UnitedHealth Group (UNH) Expected to Announce Quarterly Earnings on Thursday

UnitedHealth Group (NYSE:UNH) is expected to release its earnings data before the market opens on Thursday, April 17th. Analysts expect UnitedHealth Group to post earnings of $7.24 per share and revenue of $111.56 billion for the quarter. UnitedHealth Group has set its FY25 guidance at $29.50-30.00 EPS.Persons that are interested in registering for the company’s earnings conference call can do so using this link.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company earned $5.83 earnings per share. The business’s revenue was up 6.8% compared to the same quarter last year. On average, analysts expect UnitedHealth Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $583.43 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $514.87 and a 200-day simple moving average of $542.12. The stock has a market capitalization of $533.67 billion, a price-to-earnings ratio of 37.64, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group has a 1-year low of $438.50 and a 1-year high of $630.73.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.44%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on UNH shares. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Twenty-one research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $632.85.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.33% of the stock is owned by insiders.

Institutional Trading of UnitedHealth Group

A hedge fund recently raised its stake in UnitedHealth Group stock. Brighton Jones LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 176.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,249 shares of the healthcare conglomerate’s stock after acquiring an additional 28,231 shares during the quarter. UnitedHealth Group accounts for 0.6% of Brighton Jones LLC’s portfolio, making the stock its 24th largest position. Brighton Jones LLC’s holdings in UnitedHealth Group were worth $22,384,000 as of its most recent filing with the Securities and Exchange Commission. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.